comparemela.com

Latest Breaking News On - Neil tiwari - Page 1 : comparemela.com

PureTech Founded Entity Vedanta Biosciences Announces $106 5 Million Financing to Advance Pipeline of Defined Bacterial Consortia Therapies

Financing will enable pivotal Phase 3 study of VE303 for recurrent C. difficile infection, to begin by 3Q 2023 Funds will also support Phase 2 study of VE202 for ulcerative colitis, to begin in 2Q. | April 25, 2023

United statesSouth koreaUnited kingdomMartin heideckerAtlantic neptuneCurt labelleBernat olleChristopher viehbacherBharatt chowriraNeil tiwariDepartment of healthKorea investment securities us incBiomedical advanced researchDevelopment authorityJournal of the american medical associationPuretech health

Lifesci Acquisition II : Science 37, the Operating System for Agile Clinical Trials, Closes Business Combination with LifeSci Acquisition II Corp and Will Begin Trading on Nasdaq as SNCE

Science 37, the Operating System for Agile Clinical Trials, Closes Business Combination with LifeSci Acquisition II Corp. and Will Begin Trading on Nasdaq as SNCE .

United statesAndrew mcdonaldAdam goulburnRob faulknerCaroline paulJohnw hubbardMargie koomanNina gillEmily rollinsDavid comanNeil tiwariWilliam blairHoldings incRedmile groupLatham watkinsLifesci acquisition ii corp

Science 37 Closes Business Combination with LifeSci Acquisition II Corp and Begin Trading on Nasdaq

FinSMEs is the financial news site dedicated to covering venture capital, private equity, and merger and acquisition deals in real time!

United statesAdam goulburnRob faulknerJohnw hubbardEmily rollinsDavid comanLos angelesNeil tiwariElyse familantHoldings incRedmile groupLifesci acquisition ii corpGlobal head of corporate developmentExchange commissionWorldwide head of development operations at pfizerOperating system

vimarsana © 2020. All Rights Reserved.